ABR Radiation Oncology
ABR Radiation Oncology Primary Certification
Prostate CancerEnglish
Exam overviewPractice session
A 68-year-old with cT2N0M0 unfavorable intermediate-risk prostate adenocarcinoma (Gleason 4+3, PSA 12) is treated with definitive EBRT. Per STAMPEDE and current NCCN, what is the appropriate ADT duration?
Loading your practice session…